인쇄하기
취소

GSK to honor UK's MHRA recommendation on Seroxat

Published: 2003-06-17 06:56:00
Updated: 2003-06-17 06:56:00
Glaxo-SmithKline Korea said recently that in line with the June 10 recommendation of Medicine and Healthcare Products Regulatory Agency (MHRA) in U.K. that Seroxat (paroxetine) should not be prescribed to young depressed patients with less than 18 of age, it would accept such decision and the MHPA recommendation would be put into practice soon.

“The MHRA recommendation has nothing to do with...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.